No Data
No Data
COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs
Cosciens Biopharma Says Phase 3 DETECT-Trial Top-line Results Show Efficacy Standpoint Not Met
COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
MT Newswires Canada Stocks To Watch: Suncor; Aeterna Zentaris; K-Bro; Magellan; Maxim Power; Orezone; PHX; PyroGenesis
Aeterna Zentaris Inc. Announces Name Change To COSCIENS Biopharma Inc. To Begin Trading Under The Trading Symbol "CSCI" August 9, 2024
Shareholder Alert: Ademi LLP Investigates Whether Aeterna Zentaris Inc.'s Transaction With Ceapro Was Fair to Shareholders
No Data